EUVIMEDEUVIMED entdecken
Crossref

Generation of Murine Chimeric Antigen Receptor‐Modified T Cells for In Vivo Studies in Syngeneic Tumor Models

Mina Hosseini, Behnia Akbari, Ahmad Reza Shahverdi, Jamshid Hadjati, Mohammad Ali Faramarzi, Hamid Reza Mirzaei iD, Mohammad Hossein Yazdi

Current Protocols · 2024

DOI: 10.1002/cpz1.1107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols, 2024. Verfasst von Mina Hosseini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biotechnology, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR‐T cell therapy has emerged as a potent and effective tool in the immunotherapy of refractory cancers. However, challenges exist in their clinical application, necessitating extensive preclinical research to optimize their function. Various preclinical in vitro and in vivo models have been proposed for such purpose; among which immunocompetent mouse models serve as an invaluable tool in studying host immune interactions within a more realistic simulation of the tumor milieu. We hereby describe a standardized protocol for the generation of high‐titer γ‐retroviral vectors through transfection of the HEK293T packaging cell line. The virus‐containing supernatant is further concentrated using an inhouse concentrator solution, titrated, and applied to mouse T cells purified via a convenient and rapid method by nylon‐wool columns. Using the method presented here, we were able to achieve high titer γ‐retrovirus and highly pure mouse T cells with desirable CAR transduction efficiency. The mouse CAR T cells produced through this protocol demonstrate favorable CAR expression and viability, thus making them suitable for further in vitro/in vivo assays. © 2024 Wiley Periodicals LLC. Basic Protocol 1 : Production of γ‐retroviral vectors from retrovirus‐backbone plasmids Basic Protocol 2 : Concentration of γ‐retrovirus‐containing supernatants Basic Protocol 3 : Titration of concentrated γ‐retrovirus Basic Protocol 4 : Isolation and activation of mouse T cells Basic Protocol 5 : Transduction of activated mouse T cells, assessment of CAR expression, and expansion of CAR T cells for further in vitro/in vivo studies Support Protocol : Surface staining of cells for flow cytometric assessment of CAR expression

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenT-LymphocytesAnimalsMiceHumansHEK293 CellsImmunotherapy, AdoptiveDisease Models, AnimalRetroviridaeNeoplasmsGenetic Vectors

Stichwörter der Autor:innen

CAR T celladoptive cell therapycancer immunotherapymouse T cellssyngeneic models

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Pharmaceutical Biotechnology, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Medical Immunology, Tehran University of Medical Sciences, Tehran, Iran.
  • Vilcek Institute of Graduate Biomedical Sciences, New York University School of Medicine, New York.
  • Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Hamid Reza Mirzaei

Zitieren

APA

Hosseini, M., Akbari, B., Shahverdi, A. R., Hadjati, J., Faramarzi, M. A., Mirzaei, H. R., & Yazdi, M. H. (2024). Generation of Murine Chimeric Antigen Receptor‐Modified T Cells for In Vivo Studies in Syngeneic Tumor Models. Current Protocols. https://doi.org/10.1002/cpz1.1107

Vancouver

Hosseini M, Akbari B, Shahverdi AR, Hadjati J, Faramarzi MA, Mirzaei HR, et al. Generation of Murine Chimeric Antigen Receptor‐Modified T Cells for In Vivo Studies in Syngeneic Tumor Models. Current Protocols. 2024. doi:10.1002/cpz1.1107

BibTeX
@article{Hosseini2024,
  author = {Hosseini, Mina and Akbari, Behnia and Shahverdi, Ahmad Reza and Hadjati, Jamshid and Faramarzi, Mohammad Ali and Mirzaei, Hamid Reza and Yazdi, Mohammad Hossein},
  title = {Generation of Murine Chimeric Antigen Receptor‐Modified T Cells for In Vivo Studies in Syngeneic Tumor Models},
  journal = {Current Protocols},
  year = {2024},
  doi = {10.1002/cpz1.1107}
}
Kostenlos starten →